慢阻肺吸入给药系统的选择
本文针对慢阻肺患者吸入给药系统选择中的挑战,提出临床医生应关注三个要点:选择合适的吸入装置、评估装置是否带来症状获益、以及提供患者教育。文章通过四个病例说明,选择装置主要考虑认知功能、手部灵活性和吸气能力;随访时询问「当前治疗对呼吸有帮助吗」可指导后续调整。
要点
- 选择吸入装置需评估患者认知功能、手部灵活性和吸气能力。
- 若患者正确使用现有手持吸入器,保持装置类型连续性可能有益。
- 随访时询问「当前治疗对呼吸有帮助吗」,回答否则需评估技术和依从性。
核心结论
- 慢阻肺吸入治疗需综合考虑装置选择、症状获益评估和患者教育。
研究设计与样本
- 本文为综述,通过四个患者病例阐述慢阻肺吸入给药系统的临床考量。
主要发现
- 选择吸入装置的主要患者因素包括认知功能、手部灵活性和吸气能力。
- 若患者正确使用现有手持吸入器,保持装置类型连续性可能有益。
- 随访时询问「当前治疗对呼吸有帮助吗」可评估药物-装置疗效。
- 回答是则继续治疗并复核吸入技术;回答否则评估技术和依从性。
- 若技术良好、依从且无主观获益,可考虑更换药物或装置。
临床怎么用
- 临床选择吸入装置时应评估患者认知功能、手部灵活性和吸气能力。
- 随访时通过询问「当前治疗对呼吸有帮助吗」快速评估疗效。
- 根据患者回答和技术/依从性评估结果决定继续、教育或更换治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Challenges facing health care professionals (HCPs) in selecting an inhaled medication delivery system for patients with COPD include (1) numerous maintenance medications and combinations; (2) at least 22 different handheld inhaler devices; (3) management recommendations focusing mainly on classes of medications; (4) lack of knowledge about available medications/combinations, delivery systems, and guidelines/expert recommendations for treating patients with COPD; (5) in some countries, contracts between health insurance and pharmaceutical companies limit which medications or devices are covered. In this article, we address 3 considerations for HCPs related to treating patients with COPD: selecting an inhaled delivery system; assessing whether the inhaled medication device has provided symptomatic benefit; and providing educational materials for patients on how to use their prescribed medication device correctly. Four patient cases are presented to illustrate these clinical aspects. The main patient factors for selecting an inhaled delivery system include cognitive function, manual dexterity, and inhalation ability. Continuity of the type of handheld inhaler can be beneficial if the patient is using it correctly. To assess the efficacy of the inhaled medication-device at follow-up, HCPs can ask the patient, "Does your current treatment help your breathing?" If the response is Yes, it is appropriate to continue the therapy and to also review inhaler technique; if the response is No, then the next step is to assess the patient's inhaler technique as well as adherence. If the patient demonstrates or describes good technique, is adherent, and does not report subjective benefit, it is reasonable to change the medication or the device.
引用
- Mahler DA, Halpin DMG. Selecting an Inhaled Delivery System in COPD. Chest. 2025. PMID: 40414483. doi:10.1016/j.chest.2025.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。